Is BMO a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on The return-on-equity repair plan, with dividend (annualized) and yield at ~$6.84 CAD per share (~$4.93 USD), ~2.7%. The bear case rests on the largest near-term risk is valuation rather than fundamentals: at about 19 to 20 times trailing reported earnings and roughly 2.3 times book, BMO trades well above the multiple Canadian banks have historically carried, and the shares sit at a 52-week high after a run of roughly 43% in 2026 in US dollar terms, so the ROE plan is substantially priced in. Analysts covering it are spread from $143.80 to $180.89, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The largest near-term risk is valuation rather than fundamentals: at about 19 to 20 times trailing reported earnings and roughly 2.3 times book, BMO trades well above the multiple Canadian banks have historically carried, and the shares sit at a 52-week high after a run of roughly 43% in 2026 in US dollar terms, so the ROE plan is substantially priced in. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $143.80, -22.6% from the $185.81 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

The return-on-equity repair plan. At its Investor Day on March 26, 2026, BMO laid out a path to a sustained return on equity above 15% exiting fiscal 2027, bridged by roughly 250 basis points of core operating improvement on about 6% revenue growth per year, around 100 basis points from credit normalising, and around 50 basis points from share repurchases. The most optimistic analyst target on BMO is $180.89, -2.6% from the $185.81 price. That figure is only reachable if this thesis works close to its best case.

The largest near-term risk is valuation rather than fundamentals: at about 19 to 20 times trailing reported earnings and roughly 2.3 times book, BMO trades well above the multiple Canadian banks have historically carried, and the shares sit at a 52-week high after a run of roughly 43% in 2026 in US dollar terms, so the ROE plan is substantially priced in. Credit could turn again, and investors should note that the Q2 improvement leaned on a near-zero performing-loan provision driven partly by model changes, which is not a repeatable source of earnings. Currency is a second, separate exposure: BMO earns and reports in Canadian dollars while the NYSE line is quoted in US dollars, so a weaker Canadian dollar reduces the US-dollar value of both the share price and the dividend regardless of how the bank performs. Fiscal Q3 2026, reporting August 25, includes an expected pre-tax charge of about $1.1 billion CAD on the agreed Stonepeak sale of Transportation Finance and Vendor Finance, treated as an adjusting item but real for reported results. BMO also faces ongoing Canadian consumer litigation, including a $100 million CAD settlement of a long-running registered-plan fee class action, and a 2024 US plaintiff-firm press release announcing an investigation of potential securities claims, which as of August 2026 has not produced a filed securities class action complaint. The most pessimistic published target is $143.80, -22.6% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Canada's oldest bank, founded in 1817, spanning personal and commercial banking, wealth management and capital markets across Canada and the US Midwest.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (The return-on-equity repair plan) stalling in the reported numbers rather than in the narrative, the risk above (the largest near-term risk is valuation rather than fundamentals: at about 19 to 20 times trailing reported earnings and roughly 2.3 times book, BMO trades well above the multiple Canadian banks have historically carried, and the shares sit at a 52-week high after a run of roughly 43% in 2026 in US dollar terms, so the ROE plan is substantially priced in) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

BMO is a diversified North American bank founded in 1817, with roughly $1.5 trillion CAD in total assets as of April 30, 2026. Revenue comes from five segments: Canadian personal and commercial banking, US banking (Chicago-centred and expanded by the 2023 Bank of the West acquisition), wealth management and insurance, capital markets, and a corporate services unit that holds treasury and unallocated items. About 55% of Q2 fiscal 2026 revenue was net interest income, with the rest fee-based.

Yes. Bank of Montreal has a genuine dual listing, with the identical common shares trading on both the Toronto Stock Exchange and the New York Stock Exchange under the ticker BMO. A US brokerage buys the ordinary Canadian share, not a depositary receipt, so there is no ADR sponsor and no ADR custody fee. The two lines track each other after adjusting for the CAD to USD exchange rate, and arbitrage keeps any gap small during overlapping trading hours.

BMO reports in Canadian dollars under IFRS. Its NYSE quote, market capitalisation as computed by US data providers, and any dividend a US broker credits are in US dollars. That split creates two distinct sources of return for a US holder: how the bank performs in Canadian dollars, and where the CAD to USD rate goes. At the August 14, 2026 rate of roughly 1.39 CAD per USD, the $185.86 USD share price corresponds to about $258 CAD, and the $6.84 CAD annual dividend to about $4.93 USD.